James L. Tyree - May 20, 2021 Form 4 Insider Report for ChemoCentryx, Inc. (CCXI)

Role
Director
Signature
/s/ Susan M. Kanaya, as Attorney-in-Fact
Stock symbol
CCXI
Transactions as of
May 20, 2021
Transactions value $
-$23,956
Form type
4
Date filed
5/24/2021, 08:19 PM
Previous filing
May 13, 2021
Next filing
Dec 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCXI Common Stock Options Exercise $0 +4.66K +35.66% $0.00 17.7K May 21, 2021 Direct F1
transaction CCXI Common Stock Sale -$24K -2.45K -13.84% $9.76 15.3K May 21, 2021 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CCXI Restricted Stock Units Award +7.73K 7.73K May 20, 2021 Common Stock 7.73K Direct F4, F5
transaction CCXI Stock Option (right to buy) Award +4.5K 4.5K May 20, 2021 Common Stock 4.5K $10.06 Direct F6, F7
transaction CCXI Restricted Stock Units Options Exercise -4.66K -100% 0 May 21, 2021 Common Stock 4.66K Direct F4, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were acquired upon vesting of restricted stock units awarded on May 21, 2020.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person to cover anticipated taxes due upon vesting of restricted stock unit shares.
F3 Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $9.65 to $10.03 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
F4 Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
F5 The restricted stock units awarded on May 20, 2021, vests on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date.
F6 The option granted on May 20, 2021, vests on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Company on such date.
F7 Not applicable.
F8 100% of the restricted stock units vested on May 21, 2021. Vested shares will be delivered to the Reporting Person within thirty (30) days following vest date.